Like I said previously...They declared the company out of the investment phase 2 quarters ago.
Maybe. But I'm not sure the market believed it. The minute they pay down debt, it is verified. The more I have thought about this, the bigger deal%2
"I read this board daily. Most posters here are not too bright. Some who act like they know what they are talking about are really talking trash and don't have any idea. So here is a question for mr technical and paulanderson27 or kguttag or hillerby or any o
I can see you owning the stock and wanting to comment on it a few times a day. But 50 or 60 every day promoting and stalking others? That sounds like you are trying to con folks. I mean you have 4,400 plus posts in a little over a year. What's up with all that? Ocd? Lonely? Mentally unsound? Hypocritical projection? Frederic me and your mammie Are worried about you. Any of that gambling money left? Hope you didn't let those big wolves make a sheep out of you again like over at mudb
He is telling people not to short. Gives rules and tells people not to short stocks that seem overvalued. He Lso said don't short stocks that have a lot of other people shorting the same stock. He said don't short stocks thT might b
GE, Kofler Energies and BELECTRIC Take Highly Efficient Hybrid Power Plant into Operation
BERLIN—May 13, 2015—GE (NYSE: GE) is putting a new, highly efficient hybrid power plant into operation in Berlin. With this pioneering concept, which offers scalable capacity, GE and its project partners Kofler Energies and BELECTRIC are breaking new ground in the area of innovative, decentralized energy supply. Representatives from the involved companies were joined by guests from the worlds of politics, business, and science to witness the launch of operations at the plant.
The new hybrid power plant, which was developed by Kofler Energies and GE’s planning office BLS Energieplan, combines photovoltaic with flexible Jenbacher combined heat and power (CHP) technology and an innovative battery solution. Thanks to an intelligent energy management system and comprehensive operational oversight, the power output can be controlled to meet demands as efficiently as possible.
The plant will not only supply power and heat to the GE Power Conversion production site in Marienfelde, Germany, but it also will feed power into the grid. The system is based on a scalable business model that also can be adapted for larger units.
The centerpiece of the hybrid power plant is a Jenbacher J312 gas engine with integrated heat storage and an efficiency level of 89.2 percent. The 400 kW system covers the basic heat load of the site during the heating season and is fueled by energy-efficient natural gas. The plant enables primary energy savings of around 30 percent compared to systems that generate heat and power separately through conventional heating and external electricity procurement.
A 600 kW solar power system with an operating voltage of 1,500 volts has been installed on the roof of the production hall. All measurement readings required for monitoring and controlling the complex system can be called up and managed remotely via the central energy management system.
When the amount of power being generated is high but consumption is low, surplus power is stored in a battery with a capacity of 200 kWh. This can then be released and fed into the plant network as required to meet higher levels of demand, bringing flexibility to power generation. Surplus power only is supplied to the public grid if the battery is completely full.
The boilers, pumps and valves are controlled in a way that ensures that the system always operates efficiently and in line with demand. The data recorded makes energy consumption transparent and can be used to help adjust the power supply to meet requirements to the
The use of stem cells by athletes may become the norm someday. As drug companies conduct trials, reveal their safety and efficacy, and eventually gain FDA approval, the use of stem cells will rapidly gain traction among professional athletes. Just as reduction of inflammation is believed to decrease tissue ischemia and its negative effects in stroke patients, reduction of inflammation in muscular tissue restores proper cellular function and accelerates healing. Pluristem recently learned that an intramuscular injection of adult stem cells not only repaired the incised muscle faster than placebo, but also the contralateral side (non-surgical side) showed greater muscle force. The press release of its Phase I/II clinica
Williams Partners L.P. logo Williams Partners L.P. (NYSE:WPZ) was downgraded by research analysts at RB